Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

45.17
Delayed Data
As of Sep 22
 -1.93 / -4.10%
Today’s Change
26.26
Today|||52-Week Range
63.73
+64.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.005.4M16.3M35.0M
 
 
 
 
Cost of Goods Sold0.00130.0K252.0K534.0K
 
 
 
 
Depreciation And Amortization1.1M1.7M1.6M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income-1.1M3.6M14.5M32.7M
 
 
 
 
 
General Expenses54.2M92.0M53.5M90.7M
 
 
 
 
 
Research And Development33.6M70.7M29.0M58.8M
 
 
 
 
 
Total Operating Expenses55.3M93.8M55.4M93.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-55.3M-88.4M-39.0M-58.0M
 
 
 
 
 
Extraordinary Credit0.000.00125.0M0.00
 
 
Extraordinary Charge-1.3M0.00-236.0K-5.4M
 
 
 
 
Interest Expense On Debt209.0K57.0K----
 
 
 
Other Expenses0.000.00335.0K184.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.7M-88.5M86.1M-63.2M
 
 
 
 
 
Income Taxes0.000.00-2.0M-109.0K
 
 
 
Net Income-56.7M-88.5M84.1M-63.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.3M54.6M54.9M55.0M
 
 
 
 
 
Shares To Calculate EPS Diluted48.3M54.6M56.0M55.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.18-$1.62$1.50-$1.15
 
 
 
 
 
EPS Diluted-$1.18-$1.62$1.50-$1.15